Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,020 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

NCT05775406

Conditions
Acute Lymphocytic Leukemia, Advanced Solid Tumors, Hematologic Diseases, +13 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Completed

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

NCT03220035

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +67 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details
Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™

NCT03263026

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Oncology Specialties: Clearview Cancer Institute Huntsville, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Central Arkansas Radiation Therapy Institute Little Rock, Arkansas, United States
  • Desert Hematology Rancho Mirage, California, United States
View all 39 locations
View Trial Details
Completed

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

NCT03367299

Conditions
Acute Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • AOU Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
View all 62 locations
View Trial Details

Related conditions